Crossmark

Patient perception and treatment convenience of dabigatran versus vitamin K antagonist when used for stroke prophylaxis in atrial fibrillation: Real-world Evaluation of Long-term Anticoagulant Treatment Experience (RE-LATE) study

Crossref DOI link: https://doi.org/10.1136/openhrt-2021-001745

Published Online: 2021-12-02

Published Print: 2021-12

Update policy: https://doi.org/10.1136/crossmarkpolicy

Authors

Lee, Young-Soo

Oh, Yong Seog https://orcid.org/0000-0003-3567-6505
Choi, Eue-Keun https://orcid.org/0000-0002-0411-6372
Chern, Alan Koay Choon

Jiampo, Panyapat

Chutinet, Aurauma

Hanafy, Dicky Armein

Trivedi, Prabhav

Zhai, Dongmei
Clinical Trials ^BETA

Clinical trials referenced in this document:

nct02849509 at ClinicalTrials.gov

Documents that mention this clinical trial

Patient perception and treatment convenience of dabigatran versus vitamin K antagonist when used for stroke prophylaxis in atrial fibrillation: Real-world Evaluation of Long-term Anticoagulant Treatment Experience (RE-LATE) study
https://doi.org/10.1136/openhrt-2021-001745
Funding

Funding for this research was provided by:

Boehringer Ingelheim
License Information

License valid from 2021-12-01

Document is current

Any future updates will be listed below